Last reviewed · How we verify

Aminophyllin — Competitive Intelligence Brief

Aminophyllin (Aminophyllin) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Respiratory.

marketed Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1 Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Aminophyllin (Aminophyllin) — University of Padova.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Aminophyllin TARGET Aminophyllin University of Padova marketed Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
Oxtriphylline choline theophyllinate Warner Chilcott Llc marketed choline theophyllinate Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1 1981-01-01
Theophyllin Theophyllin University of Bergen marketed Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Aminophyllin — Competitive Intelligence Brief. https://druglandscape.com/ci/aminophyllin. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: